Aquatic Capital Management’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,700
Closed -$640K 1302
2023
Q1
$640K Sell
8,700
-2,900
-25% -$251K 0.04% 360
2022
Q4
$969K Sell
11,600
-4,200
-27% -$379K 0.07% 326
2022
Q3
$1.53M Buy
15,800
+14,900
+1,656% +$1.78M 0.15% 190
2022
Q2
$95K Buy
900
+700
+350% +$89.4K 0.03% 493
2022
Q1
$34K Buy
+200
New +$29.9K 0.05% 365

Other funds holding AMED

Aquatic Capital Management's AMED Position: Q2 2023 in Review

Aquatic Capital Management sold out of Amedisys (AMED) in Q2 2023, closing a stake of 8,700 shares — an estimated $640K sold.

Aquatic Capital Management first reported a position in AMED in Q1 2022 and held it in 5 quarters. The position peaked at $1.53M in Q3 2022. 301 funds tracked by Wall St. Rank hold AMED as of Q2 2023.

  • Aquatic Capital Management reported no remaining Amedisys position as of Q2 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 8,700 Amedisys shares in Q2 2023, an estimated $640K.
  • Aquatic Capital Management first reported a position in Amedisys in Q1 2022 and held it in 5 quarters.
  • Aquatic Capital Management's Amedisys position peaked at $1.53M in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Amedisys as of Q2 2023.

Based on Aquatic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.